Related Experiment Video
Updated: Aug 5, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Immunological Evidence of Latent Tuberculosis Infection among Noncontacts and Contacts with Index Tuberculosis
Ajoy Kumar Verma1, Raj Narayan Yadav1, Lokender Kumar2
1Department of Microbiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
Introduction:
Detecting latent tuberculosis infection (LTBI) is becoming more important in cases where the risk of disease progression is high and where anti-tuberculosis (TB) treatment is necessary. The aim of this study is to find out the immunological evidence of LTBI in terms of release of interferon-gamma (IFN-γ), using interferon-gamma release assays (IGRAs) in contacts with the index TB case and without contact individuals.
Methods:
This cross-sectional study was conducted from March 2023 to January 2024. Participants were recruited according to the inclusion and exclusion criteria, and written informed consent was obtained. Two IGRAs, QuantiFERON-TB Gold In-Tube (QFT-GIT)® and ichroma™ IGRA-TB assay, a lateral flow assay, were performed on blood samples from participants to detect LTBI.
Results:
Out of 175 participants, immunological evidence of LTBI was observed in 57 (32.5%) on either assay. By QFT-GIT® assay, positivity rates were observed as 28.8% (13/45), 18.4% (7/38), and 29.3% (27/92) in close contacts, casual contacts, and noncontacts, respectively. On the other hand, 24.5% (11/45), 15.7% (6/38), and 28.2% (26/92) positivity rates were found in the same groups through ichroma™ IGRA-TB assays. However, these differences were statistically nonsignificant. In addition, the level of agreement (76.6%) between these two assays was observed, indicating good agreement (k = 0.504).
Conclusions:
The study revealed that the positivity of the IGRA test between the contact and noncontact groups is statistically not significant. The study findings suggest that IGRA testing for LTBI could be reliable for the high-risk group rather than general screening.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...